Abhijit Kirtunia

WORK HISTORY

EDUCATION

ABOUT ABHIJIT KIRTUNIA

I am a senior strategy and corporate development leader with 17 years of experience spanning pharmaceutical M&A, business development & licensing (BD & L), integration & separation execution, and global commercial strategy across life sciences.Currently serving as Associate Director at Novartis, I work at the interface of global commercial strategy, enterprise capabilities, and country market execution — translating strategic priorities into operational reality across international markets.Key Competencies: M&A & BD & L Execution: End-to-end support across deal lifecycle — target screening, financial due diligence, valuation modeling (DCF, scenario analysis), NBO preparation, cDD support, and post-deal integration. Active support on 5+ large transactions at Novartis; 1 NBO submission; 1 deal in commercial due diligence phase. Integration & Separation Leadership: Led I&S PMO planning from deal signing through Day 1 and D180. Covered asset acquisitions (GSK, Astellas) and divestments (Novartis, including TSA scoping, marketing authorization transfers, and technology transfer readiness. Corporate Finance & Valuation: Pro-forma financial modeling (IS, CF, BS), DCF, sensitivity and scenario analyses. Extensive use of Capital IQ and FactSet for valuation multiples, transaction comparables, and peer benchmarking. Strategic Governance & PMO: Designed and led governance frameworks, KPI dashboards, and stakeholder escalation structures across enterprise-scale transformation programs in global matrix organizations. People Leadership: Managing multiple direct reports. Deputy Lead — Integration & Separation Capability Group,supporting GATE assessments and capability development.Academic Pedigree:Pursuing PhD in Finance (M&A, PE/VC Investments) at IIT Kharagpur (Year 4)| MBA Finance, FMS Delhi (Rank 5)| B.Tech Biotechnology, Anna University (Rank 5, 9.3 CGPA)Areas of Interest:Biotech innovation & valuation · Strategic partnerships & licensing · AI and digital transformation in healthcare · Evolving commercialization models in life sciences · PE/VC investment frameworksOpen to Director / VP-level opportunities in M&A, Corporate Development, BD & L, and Strategy within global life sciences and healthcare organizations.